( NASDAQ-SMALL:ACHV )

News from Achieve Life Sciences, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 28, 2017, 05:30 ET Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Nov 14, 2017, 05:30 ET Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Nov 08, 2017, 05:30 ET Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Nov 06, 2017, 08:31 ET Achieve Announces Availability of Company Presentation from the Virtual Investor Conference

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Oct 30, 2017, 08:31 ET Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017

Company invites individual and institutional investors and advisors to attend virtualinvestorconferences.com Achieve Life Sciences, Inc....


Oct 26, 2017, 05:30 ET Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Oct 04, 2017, 05:30 ET Achieve Announces Advancement of Cytisine Clinical Development Program

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Sep 14, 2017, 16:05 ET Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Aug 16, 2017, 06:00 ET Achieve Announces Initiation of Cytisine Clinical Development Program

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Aug 10, 2017, 16:30 ET Achieve Announces FDA Acceptance of the Investigational New Drug Application (IND) for Cytisine as a Smoking Cessation Treatment

Strategic Collaboration with the National Institutes of Health (NIH) Instrumental in Facilitating IND-enabling Studies Achieve Life...